Apitope's Grant

Apitope raised a round of funding on January 13, 2014. Investors include Seventh Framework Programme.

Apitope is a European biotech company focused on the discovery and development of revolutionary disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves' …

Articles about Apitope's Grant: